Facebook
Twitter
LinkedIn
Forward2019: Survivorship after Cancer of the Head and Neck:
Intent and Overview
The purpose of this symposium is to provide fundamental information necessary for a comprehensive approach to survivorship care of head and neck cancer patients. This symposium is intended to improve healthcare providers’ ability to provide high-quality survivorship care to the growing population of head and neck cancer survivors.
Target Audience
Professional providers, cancer survivors, primary care physicians, nurses, residents, audiologists, speech-language pathologists, physical therapists, dentists and other interested healthcare professionals.
Learning Objectives
At the completion of the course, the participant should be able to:
1. Recognize the components of high-quality head and neck cancer survivorship care.
2. Identify prevailing late and long-term effects head and neck cancer survivors’ experience.
3. Describe strategies and interventions to address the complex needs of head and neck cancer survivors.
4. Recognize new systemic therapies for head and neck cancer and potential side effects.
Additional Information
| Attachment | Size |
|---|---|
 Handout Updated 2019 (008) APPROVED.pdf | 342.8 KB |
SCHEDULE
Day 1 of 2: Monday, August 5, 2019
Location: UPMC Herberman Conference Center
7:00 – 8:00 am Registration and Breakfast
8:00 – 8:05 am Welcome
Jonas Johnson, MD
Moderator: Jonas Johnson, MD
8:05 – 8:45 am Cancer Survivorship: A Growing Challenge for Cancer Care
Julia Rowland, PhD
8:45 – 9:15 am Burden of Treatment
Marci Nilsen, PhD, MSN, RN
9:15 – 9:45 am Patient Experience: Journey from Diagnosis to Survivorship
Moderator: Marci Nilsen, PhD, MSN, RN
9:45 – 10:15 am Functional Reconstruction in Head and Neck Cancer
Mario Solari, MD
10:15 – 10:45 am Body Image After Head and Neck Cancer
Evan Graboyes, MD
10:45 – 11:00 am BREAK
11:00 – 11:30 am Expanding the Horizons of Minimally Invasive Surgery
11:30 – 12:00 pm Panel Discussion: Enhancing Function and Cosmesis : Practical Considerations
Moderator: Shaum Sridharan, MD
Panelists: Uma Duvvuri, MD, PhD; Evan Graboyes, MD; Karen Scuilli, MBA, MSN, RN; Mario Solari, MD;
12:00 – 1:00 pm LUNCH
Moderator: Marci Nilsen, PhD, MSN, RN
1:00 – 1:30 pm Advances in Systemic Therapies: Implications for Survivorship
Dan Zandberg, MD
1:30 – 2:00 pm Advances in Radiotherapies: Therapeutic Outcomes in Head and Neck Cancer
Heath Skinner, MD, PhD
2:00 – 2:30 pm Proffered Paper Session (No CME credit awarded)
Selected Oral Presentation
2:30 – 3:00 pm Poster Session
Moderator: Tamara Wasserman-Wincko, MD, CCC-SLP
3:00 – 3:45 pm Dysphagia After Head and Neck Cancer: Can we Cure the Cured
3:45– 4:15 pm Current Practice in Lymphoedema Treatment After Head and Neck Cancer
Karen Losego, PT, DPT, CLT-LANA
4:15– 5:00 pm Panel Discussion: Comprehensive Rehabilitative Strategies
Moderator: Susan George, PT, DPT, MS, OCS, WCS
Panelists: Karen Losego, PT, DPT, CLT-LANA; Timothy McCulloch, MD; Tamara Wasserman-Wincko, MD, CCC-SLP
5:00 pm Adjournment Day 1 of 2
Day 2 of 2: Tuesday, August 6, 2019
Location: UPMC Herberman Conference Center
7:00 – 7:55 am Registration and Breakfast
7:55 – 8:00 am Welcome
Jonas Johnson, MD
Moderator: Elizabeth Pawlowicz, DMD
8:00 – 8:45 am Optimizing Oral Care in Head and Neck Cancer Patients
8:45 – 9:15 am Strategies for Complimentary Therapy in Cancer Care
9:15 – 9:45 am Pharmacologic Strategies for Symptom Control
9:45 – 10:30 am Panel Discussion: Management of the Cascade of Symptoms After Therapy
Moderator: Heath Skinner, MD, PhD
Panelists: Mark Chambers, DMD, MS; David Clump, MD; Lanie Francis, MD; Brian Zitelli, Pharm D
10:30 – 10:45 am BREAK
Moderator: Marci Nilsen, PhD, MSN, RN
10:45 – 11:30 am Self-Advocacy Navigating Cancer Care and Survivorship
11:30 -- 12:00 pm Proffered Papers (No CME credit awarded)
Selected Oral Presentation
12:00 – 12:30 pm Looking to the Future
Marci Nilsen, PhD, MSN, RN; Jonas Johnson, MD
12:30 pm Adjournment Day 2 of 2
All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
The following relevant financial relationships were disclosed:
Mark Chambers, DMD, MS | Greater Houston Dental Society – CE Speakers’ Bureau |
David Clump, MD, PhD | AstraZeneca – Grant/Research Support Easle Pharmaceuticals -- Consultant |
Uma Duvvuri, MD, PhD | Medtronic – Consultant Activ Surgical -- Consultant |
Evan Graboyes, MD | National Cancer Institute – Grant/Research Support American Cancer Society – Grant/Research Support American Academy of Otolaryngology—Head and Neck Surgery Foundation – Grant/Research Support |
Karen, Scuilli, MBA, MSN, RN | Shadyside Hospital Foundation – Grant/Research Support Jewish Healthcare Foundation – Grant/Research Support |
Dan Zandberg, MD | I receive effort for my role as PI for trials with Merck, Bristol Myers Squibb, AstraZeneca -- Other |
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
CME Accreditation and Designation Statement:
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this live activity for a maximum of 9.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals are awarded 0.9 continuing education units (CEU’s) which are equal to 9.5 contact hours.
Available Credit
- 9.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 9.50 Attendance